Novamind Inc. (CSE: NM) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference
Novamind Inc. (CSE: NM) is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. To learn more about the company, visit www.novamind.ca To view IBN’s virtual coverage of Benzinga’s upcoming Cannabis Capital Conference, visit https://ibn.fm/BenzingaCannabisFeb2021 For registration information and further details…







